Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Urology ; 192: e107-e109, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-38906267

RESUMO

Fibroepithelial polyps in the urinary tract are a rare cause of obstructive uropathy with fewer than 130 cases reported in the literature. In our series, we describe polyps that were missed on preoperative imaging and later found in the operating room during pyeloplasty. It is critical for urologists to be aware of polyps as a potential source of obstruction as they can increase the complexity of a reconstruction and, if missed, may result in a failed repair and persistent obstruction. We hypothesize that performing a retrograde pyelogram prior to ureteric reconstruction will facilitate diagnosis prior to surgical repair.


Assuntos
Pólipos , Obstrução Ureteral , Humanos , Pólipos/cirurgia , Pólipos/diagnóstico , Masculino , Feminino , Obstrução Ureteral/cirurgia , Obstrução Ureteral/etiologia , Obstrução Ureteral/diagnóstico , Neoplasias Ureterais/diagnóstico , Neoplasias Ureterais/cirurgia , Neoplasias Ureterais/patologia , Pessoa de Meia-Idade , Adulto
3.
Urology ; 166: 223-226, 2022 08.
Artigo em Inglês | MEDLINE | ID: mdl-35461916

RESUMO

OBJECTIVE: To report on our experience performing office-based pediatric urologic procedures. We hypothesize that office-based interventions are safe and effective for children, avoiding unnecessary risk and cost associated with general anesthesia. METHODS: We retrospectively identified patients undergoing office-based interventions from 2014 to 2019, including lysis of penile or labial adhesions, division of skin bridges, meatotomy and excision of benign lesion. Success was defined as a completed attempt in the office. Failure includes any unsuccessful office attempts. Complications include 30-day ED visits/readmissions and recurrent skin bridge post division of skin bridge. RESULTS: We identified 1326 interventions: 491 lyses of penile adhesions (37%), 320 division of skin bridges (24%), 128 lyses of labial adhesions (10%), 348 meatotomies (26%), and 39 excisions of benign lesions (3%) [Table 1]. There was a >95% success rate reported in every procedure with an overall complication rate of 0.6%. Excision of benign lesion had 100% success rate. ED visits within 30 days are rare (0.2%), and no patients required admission after their procedure [Table 2]. The rate of recurrence was highest following lysis of labial adhesions (13.3%). Of the 54 patients who underwent retreatment, very few required general anesthesia (n = 6). CONCLUSION: Office-based urologic interventions in children are well tolerated with excellent safety and efficacy. Complications and recurrence are universally low. Ultimately, 99.5% of this cohort was managed under local anesthetics, thereby avoiding the risks of anesthesia use in the pediatric population.


Assuntos
Procedimentos Cirúrgicos Ambulatórios , Anestésicos Locais , Procedimentos Cirúrgicos Ambulatórios/métodos , Anestesia Geral , Criança , Estudos de Coortes , Humanos , Estudos Retrospectivos
4.
Int. braz. j. urol ; 43(6): 1021-1032, Nov.-Dec. 2017. tab
Artigo em Inglês | LILACS | ID: biblio-892920

RESUMO

ABSTRACT As patients with end-stage renal disease are receiving renal allografts at older ages, the number of male renal transplant recipients (RTRs) being diagnosed with prostate cancer (CaP) is increasing. Historically, the literature regarding the management of CaP in RTR's is limited to case reports and small case series. To date, there are no standardized guidelines for screening or management of CaP in these complex patients. To better understand the unique characteristics of CaP in the renal transplant population, we performed a literature review of PubMed, without date limitations, using a combination of search terms including prostate cancer, end stage renal disease, renal transplantation, prostate cancer screening, prostate specific antigen kinetics, immuno-suppression, prostatectomy, and radiation therapy. Of special note, teams facilitating the care of these complex patients must carefully and meticulously consider the altered anatomy for surgical and radiotherapeutic planning. Active surveillance, though gaining popularity in the general low risk prostate cancer population, needs further study in this group, as does the management of advance disease. This review provides a comprehensive and contemporary understanding of the incidence, screening measures, risk stratification, and treatment options for CaP in RTRs.


Assuntos
Humanos , Masculino , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/etiologia , Neoplasias da Próstata/terapia , Neoplasias da Próstata/epidemiologia , Transplante de Rim/efeitos adversos , Incidência , Antígeno Prostático Específico/sangue , Medição de Risco
5.
Int Braz J Urol ; 43(6): 1021-1032, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28338305

RESUMO

As patients with end-stage renal disease are receiving renal allografts at older ages, the number of male renal transplant recipients (RTRs) being diagnosed with prostate cancer (CaP) is increasing. Historically, the literature regarding the management of CaP in RTR's is limited to case reports and small case series. To date, there are no standardized guidelines for screening or management of CaP in these complex patients. To better understand the unique characteristics of CaP in the renal transplant population, we performed a literature review of PubMed, without date limitations, using a combination of search terms including prostate cancer, end stage renal disease, renal transplantation, prostate cancer screening, prostate specific antigen kinetics, immunosuppression, prostatectomy, and radiation therapy. Of special note, teams facilitating the care of these complex patients must carefully and meticulously consider the altered anatomy for surgical and radiotherapeutic planning. Active surveillance, though gaining popularity in the general low risk prostate cancer population, needs further study in this group, as does the management of advance disease. This review provides a comprehensive and contemporary understanding of the incidence, screening measures, risk stratification, and treatment options for CaP in RTRs.


Assuntos
Transplante de Rim/efeitos adversos , Neoplasias da Próstata , Humanos , Incidência , Masculino , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/epidemiologia , Neoplasias da Próstata/etiologia , Neoplasias da Próstata/terapia , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA